Stuttgart - Delayed Quote • EUR
Nektar Therapeutics (ITH.SG)
At close: April 26 at 10:32 AM GMT+2
Key Executives
Key Executives Information Not Available
Nektar Therapeutics
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Nektar Therapeutics’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
May 07, 2024 - May 13, 2024
Nektar Therapeutics Earnings Call
Related Tickers
INTS Intensity Therapeutics, Inc.
3.9250
+2.75%
FBLG FibroBiologics, Inc.
10.11
-13.44%
ANRO Alto Neuroscience, Inc.
14.18
+0.35%
PHRM.CN PharmaTher Holdings Ltd.
0.2400
-2.04%
TRVI Trevi Therapeutics, Inc.
2.7800
+9.45%
CYCC Cyclacel Pharmaceuticals, Inc.
1.5100
-5.63%
ACXP Acurx Pharmaceuticals, Inc.
2.0700
+2.48%
PMVP PMV Pharmaceuticals, Inc.
1.7500
+2.34%
GOVX GeoVax Labs, Inc.
1.4200
-3.40%
TCRX TScan Therapeutics, Inc.
7.32
+0.41%